Rasmus Sejersten Ripa

Rasmus Sejersten Ripa

Postdoc, Clinical Associate Professor

ORCID: 0000-0003-2035-2321

Publication year:
All
1 - 8 out of 8Page size: 10
  1. 2006

  2. Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy?

    Kastrup, J., Ripa, Rasmus Sejersten, Wang, Y. & Jørgensen, E., Dec 2006, In: European Heart Journal. 27, 23, p. 2748-54 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Influences of electrocardiographic ischaemia grades and symptom duration on outcomes in patients with acute myocardial infarction treated with thrombolysis versus primary percutaneous coronary intervention: results from the DANAMI-2 trial

    Sejersten, M., Birnbaum, Y., Ripa, Rasmus Sejersten, Maynard, C., Wagner, G. S., Clemmensen, P. & DANAMI-2 Investigators, D. I., Nov 2006, In: Heart. 92, 11, p. 1577-82 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Epo 'cytokine-doping' of heart disease patients, will it work?

    Jørgensen, E., Bindslev, L., Ripa, Rasmus Sejersten & Kastrup, J., Aug 2006, In: European Heart Journal. 27, 15, p. 1767-8 2 p.

    Research output: Contribution to journal › Journal article › Research

  5. Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease

    Ripa, Rasmus Sejersten, Wang, Y., Jørgensen, E., Johnsen, H. E., Hesse, B. & Kastrup, J., Aug 2006, In: European Heart Journal. 27, 15, p. 1785-92 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. In-stent neo-intimal hyperplasia after stem cell mobilization by granulocyte-colony stimulating factor Preliminary intracoronary ultrasound results from a double-blind randomized placebo-controlled study of patients treated with percutaneous coronary intervention for ST-elevation myocardial infarction (STEMMI Trial)

    Jørgensen, E., Ripa, Rasmus Sejersten, Helqvist, S., Wang, Y., Johnsen, H. E., Grande, P. & Kastrup, J., 28 Jul 2006, In: International Journal of Cardiology. 111, 1, p. 174-7 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention

    Wang, Y., Johnsen, H. E., Mortensen, S., Bindslev, L., Ripa, Rasmus Sejersten, Haack-Sørensen, M., Jørgensen, E., Fang, W. & Kastrup, J., Jun 2006, In: Heart. 92, 6, p. 768-74 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Usefulness of quantitative baseline ST-segment elevation for predicting outcomes after primary coronary angioplasty or fibrinolysis (results from the DANAMI-2 trial)

    Sejersten, M., Ripa, Rasmus Sejersten, Maynard, C., Wagner, G. S., Andersen, H. R., Grande, P., Mortensen, L. S. & Clemmensen, P., 1 Mar 2006, In: American Journal of Cardiology. 97, 5, p. 611-6 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial

    Ripa, Rasmus Sejersten, Jørgensen, E., Wang, Y., Thune, J. J., Nilsson, J. C., Søndergaard, Lars, Johnsen, H. E., Køber, Lars Valeur, Grande, P. & Kastrup, J., 2006, In: Circulation. 113, 16, p. 1983-92 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 45867987